Attached files
| file | filename |
|---|---|
| 10-Q - FORM 10Q - ANTIVIRAL TECHNOLOGIES, INC. | antiviral10qfinal.htm |
| EX-31 - EXHIBIT 31.2 - ANTIVIRAL TECHNOLOGIES, INC. | exhibit312.htm |
| EX-31 - EXHIBIT 31.1 - ANTIVIRAL TECHNOLOGIES, INC. | exhibit311.htm |
| EX-32 - EXHIBIT 32.2 - ANTIVIRAL TECHNOLOGIES, INC. | exhibit322.htm |
Exhibit 32.1
CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the Quarterly Report of ANTIVIRAL TECHNOLOGIES, INC. (the "Company") on Form 10-Q for the period ended March 31, 2014 (the "Report"), I, Patricia Yee Ying Leung, Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:
1) The Report fully complies with the requirement of Section 13(a) or 15 (d) of the Securities Exchange Act of 1934; and
2) The information contained in the Report fairly presents, in all material respects, the Company's financial position and results of operations.
By: /s/ Patricia Yee Ying Leung, CEO
Date: May 15, 2014